Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Nyu Langone Appoints Roxana Fu, Md As Chief of Oculoplastics

PRIVATESep 06, 2024•almost 2 years ago

Company

NYU Langone Health

New YorkBiotechnologyHealth CareMedicalTherapeutics

Description

Roxana Fu, MD, a leader in innovative approaches in oculoplastic and orbital eye surgery, has been appointed as the chief of oculoplastics for NYU Langone's Department of Ophthalmology at NYU Grossman School of Medicine. Dr. Fu brings dedication to patient-centered care and cutting-edge research to the department and the NYU Langone Eye Center.

Company Information

Company

NYU Langone Health

Location

New York, New York, United States

About

As a specialist in the field of cardio-oncology, Dr. Bloom focuses on early prevention, detection, treatment, and management of the potential cardiac effects of cancer treatments so that patients can safely continue their therapies. She will lead the system-wide program, which unites cardiologists, oncologists, immunologists and researchers from both NYU Langone Heart and NYU Langone's Perlmutter Cancer Center, to coordinate personalized cardiac care designed with our cancer patients in mind. Dr. Bloom and the team also offer specialized treatment to cancer survivors so that their risk of cardiovascular disease can be recognized early and minimized. Dr. Bloom has been a pioneer in the field, publishing in peer-reviewed journals on how to best provide cardio-oncology care.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for NYU Langone Health's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months